Clinical Trial Update: A Study in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) Receiving Vedolizumab in Real-World Practice in Switzerland

View source ↗

Summary

A completed real-world study evaluating vedolizumab use in adults with inflammatory bowel diseases (Crohn's disease and ulcerative colitis) in Switzerland.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Ulcerative Colitis

Drugs mentioned

• Vedolizumab (vedolizumab)

Snippet

Sponsor: Takeda | Conditions: Inflammatory Bowel Diseases, Crohns Disease | Status: COMPLETED